MWP
GILD icon

Meridian Wealth Partners’s Gilead Sciences GILD Stock Holding History

Meridian Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,506
Closed -$210K – 129
2026
Q1 		$210K Buy
+1,506
New +$211K 0.03% 113
2021
Q2 		– Sell
-494
Closed -$32K – 552
2021
Q1 		$32K Buy
+494
New +$31.9K 0.01% 207
2020
Q3 		– Sell
-337
Closed -$26K – 217
2020
Q2 		$26K Buy
337
+18
+6% +$1.38K 0.01% 173
2020
Q1 		$24K Buy
+319
New +$22K 0.01% 163

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Meridian Wealth Partners's GILD Position: Q2 2026 in Review

Meridian Wealth Partners sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,506 shares — an estimated $210K sold.

Meridian Wealth Partners first reported a position in GILD in Q1 2020 and held it in 4 quarters. The position peaked at $210K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Meridian Wealth Partners reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Meridian Wealth Partners sold 1,506 Gilead Sciences shares in Q2 2026, an estimated $210K.
  • Meridian Wealth Partners first reported a position in Gilead Sciences in Q1 2020 and held it in 4 quarters.
  • Meridian Wealth Partners's Gilead Sciences position peaked at $210K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Meridian Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.